Johnson & Johnson Inc.

If, a few years from now, there's a budding cycling rivalry between the Lehigh Valley and Philadelphia, it'll primarily be because Lisa Nutter coaxed her husband to make the ride to Trexlertown to watch her ride the past two years. Lisa Nutter's husband happens to be Michael Nutter, the current mayor of Philadelphia, and a year ago he came to the Valley Preferred Cycling Center to watch his wife compete for a team from Philadelphia City Hall in the annual Rodale Corporate Challenge. Impressed with the facility, and eyeing the benefits a similar facility could bring to his city, Nutter put his political clout behind an effort to bring a velodrome to south Philadelphia. If...

Related "Johnson & Johnson Inc." Articles

If, a few years from now, there's a budding cycling rivalry between the Lehigh Valley and Philadelphia, it'll primarily be because Lisa Nutter coaxed her husband to make the ride to Trexlertown to watch her ride the past two years.Lisa Nutter's husband...

Night driving entails a whole host of challenges, not the least of which is the frequency with which that same sappy love song pops up on station after station.
Lovelorn call-in shows aside, driving in the dark poses very real dangers to your physical...

(Reuters) - Johnson & Johnson has told doctors it expects a limited supply of its Doxil cancer drug to become available within the next six weeks, but warned the amount would not be sufficient for all patients currently on waiting lists.
Supplies...

LONDON (Reuters) - Johnson & Johnson's prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed after chemotherapy, the company said on Wednesday.
The...

PARIS (Reuters) - An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market.
Although Eliquis will...

LOS ANGELES (Reuters) - U.S. regulators are moving quickly with Roche's application for targeted melanoma drug vemurafenib, which could receive approval as early as this week, according to a source familiar with the situation.
A pivotal trial found...

Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday.
The drugs, known as "atypical...